All Pharma News
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012

ExeVir Bio Announces Positive Virus Neutralization Data for XVR012
GLOBENEWSWIRE
15 Jan 2024
Share Share
ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research
GLOBENEWSWIRE
28 Jun 2023
Share Share
ExeVir Bio and VIB Announce Data on a New Therapy for Treatment for COVID-19

ExeVir Bio and VIB Announce Data on a New Therapy for Treatment for COVID-19
GLOBENEWSWIRE
13 Mar 2023
Share Share
ExeVir secures EUR 25M venture debt financing from European Investment Bank

ExeVir secures EUR 25M venture debt financing from European Investment Bank
GLOBENEWSWIRE
09 Jan 2023
Share Share
ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy
PRNEWSWIRE
20 Oct 2022
Share Share
ExeVir hits pause on llama-derived Covid antibody amid Omicron variants

ExeVir hits pause on llama-derived Covid antibody amid Omicron variants
Kyle LaHucik ENDPTS
09 May 2022
Share Share
ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinical Study

ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinical Study
PRNEWSWIRE
01 Sep 2021
Share Share
ExeVir doses first patients with llama-derived anti-Covid antibody

ExeVir doses first patients with llama-derived anti-Covid antibody
Max Gelman (Editor) ENDPOINTS
18 Aug 2021
Share Share
ExeVir, Mithra CDMO Enter Manufacturing Collaboration

ExeVir, Mithra CDMO Enter Manufacturing Collaboration
CONTRACT PHARMA
21 Jul 2021
Share Share
ExeVir and Mithra announce manufacturing collaboration

ExeVir and Mithra announce manufacturing collaboration
PR NEWSWIRE
15 Jul 2021
Share Share